---
layout: splash
title: 삼성바이오로직스 (207940)
excerpt: 삼성바이오로직스의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
- 고PER
keywords: 삼성바이오로직스, 207940
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 790,000 | <span style="color: cornflowerblue">-0.6<small>%</small></span> | P:의약품 | 69.0 | 6.3 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 기초 의약물질 및 생물학적 제제 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 바이오의약품 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 2016년 11월 10일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 임존종보 (Rim John Chongbo) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.samsungbiologics.com](http://www.samsungbiologics.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 04&#x2011;09 | | [결산실적공시예고(안내공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240409800497){:target="_blank"} |
| 04&#x2011;05 | | [임원ㆍ주요주주특정증권등소유상황보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240405002898){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![207940](/stock/images/207940.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 790,000 | <span style="color: cornflowerblue">-0.6<small>%</small></span> | <span style="color: cornflowerblue">-3.3<small>%</small></span> | <span style="color: cornflowerblue">-6.0<small>%</small></span> | <span style="color: tomato">3.4<small>%</small></span> | <span style="color: tomato">12.2<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-1.2<small>%</small></span> | 24.7<small>%</small> | -0.05 | -16.8<small>%</small> | -7.3<small>%</small> | 0.1 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 69.0 | 6.3 | - | 고PER |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/207940/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=207940){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A207940&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=207940){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/207940){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/207940/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![207940](/stock/images/207940_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -1.2<small>%</small> | 24.7<small>%</small> | -0.05 | -16.8<small>%</small> | -7.3<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 3.6<small>%</small> | 24.5<small>%</small> | 0.15 | -14.9<small>%</small> | -5.6<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 2.9<small>%</small> | 19.3<small>%</small> | 0.15 | -10.4<small>%</small> | -4.4<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -11.8<small>%</small> | 16.7<small>%</small> | -0.71 | -20.0<small>%</small> | -12.9<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -10.6<small>%</small> | 16.8<small>%</small> | -0.63 | -21.5<small>%</small> | -11.3<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -5.2<small>%</small> | 17.3<small>%</small> | -0.30 | -17.0<small>%</small> | -9.1<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -3.8<small>%</small> | 15.2<small>%</small> | -0.25 | -9.9<small>%</small> | -4.4<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -4.0<small>%</small> | 13.3<small>%</small> | -0.30 | -9.9<small>%</small> | -1.8<small>%</small> |
| MACD[^fn_tech_metric_macd] | -3.4<small>%</small> | 19.3<small>%</small> | -0.18 | -13.0<small>%</small> | -6.4<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![207940](/stock/images/207940_corr.png){: .align-center}

|       | [하나투어](/039130/) | [한국가스공사](/036460/) | [씨젠](/096530/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [엔켐](/348370/) | [셀트리온제약](/068760/) | [HLB생명과학](/067630/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![207940](/stock/images/207940_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info} [고PER 목록](/fn/fn_high_per/){: .btn .btn--info}

{% include commons/footnotes.md %}